Avidity Biosciences (RNA) Earnings Date, Estimates & Call Transcripts $42.19 +0.44 (+1.05%) (As of 09/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 13EstimatedActual EPS (Aug. 9) -$0.65 Beat By $0.11 Consensus EPS (Aug. 9) -$0.76 Conference Call TranscriptConference Call AudioEarnings Press Release Get Avidity Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for RNA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RNA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Gold RepublicCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold. Click here now to get your free 'Protect Your Wealth' Guide. Avidity Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.78)($0.78)($0.78)Q2 20241($0.80)($0.80)($0.80)Q3 20241($0.83)($0.83)($0.83)Q4 20241($0.87)($0.87)($0.87)FY 20244($3.28)($3.28)($3.28)Q1 20251($0.88)($0.88)($0.88)Q2 20251($0.90)($0.90)($0.90)Q3 20251($0.92)($0.92)($0.92)Q4 20251($0.93)($0.93)($0.93)FY 20254($3.63)($3.63)($3.63)RNA Earnings Date and InformationAvidity Biosciences last released its quarterly earnings data on August 9th, 2024. The biotechnology company reported ($0.65) EPS for the quarter, topping the consensus estimate of ($0.76) by $0.11. The company earned $2.05 million during the quarter, compared to analysts' expectations of $7.09 million. Avidity Biosciences has generated ($2.95) earnings per share over the last year (($2.95) diluted earnings per share). Earnings for Avidity Biosciences are expected to decrease in the coming year, from ($3.01) to ($3.18) per share. Avidity Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off prior year's report dates.Read More Avidity Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/13/2024(Estimated)------- 8/9/2024-($0.76)($0.65)+$0.11($0.65)$7.09 million$2.05 million 5/15/2024-($0.81)($0.79)+$0.02($0.79)$7.09 million$3.54 million 2/28/2024Q4 2023($0.54)($0.79)($0.25)($0.79)$32.08 million$2.19 million 11/8/2023Q3 2023($0.76)($0.71)+$0.05($0.71)$2.09 million$2.82 million 8/8/2023Q2 2023($0.84)($0.66)+$0.18($0.66)$2.09 million$2.32 million 5/9/2023Q1 2023($0.90)($0.74)+$0.16($0.74)$2.08 million$2.23 million Get the Latest News and Ratings for RNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/2023Q4 2022($0.84)($0.88)($0.04)($0.88)$2.39 million$2.77 million 11/8/2022Q3 2022($0.97)($0.82)+$0.15($0.82)$2.39 million$2.48 million 8/9/2022Q2 2022($0.74)($0.92)($0.18)($0.92)$2.29 million$2.18 million 5/10/2022Q1 2022($0.94)($0.71)+$0.23($0.71)$1.50 million$1.80 million 3/1/2022Q4 2021($0.73)($0.82)($0.09)($0.82)$2.20 million$1.85 million 11/9/2021Q3 2021($0.68)($0.68)-($0.68)$1.50 million$2.16 million 8/8/2021Q2 2021($0.71)($0.70)+$0.01($0.70)$1.50 million$2.61 million 5/11/2021Q1 2021($0.56)($0.64)($0.08)($0.64)$1.50 million$2.70 million 3/14/2021Q4($0.3430)($0.43)($0.0870)($0.43)-$2.14 million11/10/2020Q3 2020($0.37)($0.31)+$0.06($0.31)-$1.75 million8/10/2020Q2($0.24)($1.23)($0.99)($1.23)-$1.54 million Avidity Biosciences Earnings - Frequently Asked Questions When is Avidity Biosciences's earnings date? Avidity Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 13th, 2024 based off last year's report dates. Learn more on RNA's earnings history. Did Avidity Biosciences beat their earnings estimates last quarter? In the previous quarter, Avidity Biosciences (NASDAQ:RNA) reported ($0.65) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.76) by $0.11. Learn more on analysts' earnings estimate vs. RNA's actual earnings. How can I listen to Avidity Biosciences's earnings conference call? The conference call for Avidity Biosciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Avidity Biosciences's conference call transcript? The conference call transcript for Avidity Biosciences's latest earnings report can be read online. Read Transcript How much revenue does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded annual revenue of $10.60 million. How much profit does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded net income of -$212.22 million. RNA has generated -$2.95 earnings per share over the last four quarters. What is Avidity Biosciences's EPS forecast for next year? Avidity Biosciences's earnings are expected to decrease from ($3.01) per share to ($3.18) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PTC Therapeutics Earnings Results ORIC Pharmaceuticals Earnings Results Solid Biosciences Earnings Results Nkarta Earnings Results Genmab A/S Earnings Results Viatris Earnings Results Dr. Reddy's Laboratories Earnings Results Vaxcyte Earnings Results Sarepta Therapeutics Earnings Results Catalent Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:RNA) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersBig News: How the Upcoming Rate Cut and Elon Musk’s AI Could Transform Your InvestmentsThe Federal Reserve is almost certainly about to cut interest rates, and history tells us that stocks often ra...InvestorPlace | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredTrillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.